CA3252332A1 — Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
Assigned to Cytokinetics Inc · Expires 2025-06-04 · 1y expired
What this patent protects
Provided are compounds of Formula (I): (see Formula I) or a pharmaceutically acceptable salt thereof, wherein A, Z, B, R1, R2, R3, Gi, G2,and G3 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (I), or a pharmaceut…
USPTO Abstract
Provided are compounds of Formula (I): (see Formula I) or a pharmaceutically acceptable salt thereof, wherein A, Z, B, R1, R2, R3, Gi, G2,and G3 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (I), or a pharmaceutically acceptable salt thereof, for use in methods of treatment of heart diseases through cardiac sarcomere inhibition.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.